Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108, United States.
ACS Biomater Sci Eng. 2021 Apr 12;7(4):1506-1514. doi: 10.1021/acsbiomaterials.1c00031. Epub 2021 Mar 11.
In this work, we have brought the release of glucagon under the control of light. The aim of this approach is to allow minimally invasive, two-hormone control of blood glucose. Glucagon has two major challenges associated with its therapeutic application: (1) the required amount and timing of glucagon release is highly variable, and (2) glucagon rapidly fibrillates in solution, forming aggregates that are inactive. We have developed a light activated glucagon trimer, in which we have joined three glucagon molecules via light cleaved linkers. We demonstrated that this material can be stimulated by light to release glucagon in a predictable manner. In addition, we demonstrated that in the absence of light, the trimer does not form fibrils and thus releases normal unfibrillated glucagon upon irradiation. These qualities make this material ideal for incorporation into a two hormone light-activated artificial pancreas system.
在这项工作中,我们实现了胰高血糖素的光控释放。这种方法的目的是允许对血糖进行微创、双激素控制。胰高血糖素有两个主要的治疗应用挑战:(1)所需的胰高血糖素释放量和时间高度可变,(2)胰高血糖素在溶液中迅速纤维化,形成无活性的聚集体。我们开发了一种光激活的胰高血糖素三聚体,其中我们通过光裂解接头将三个胰高血糖素分子连接在一起。我们证明,这种材料可以通过光刺激以可预测的方式释放胰高血糖素。此外,我们证明在没有光的情况下,三聚体不会形成纤维,因此在照射时会释放正常的无纤维胰高血糖素。这些特性使这种材料非常适合纳入到双激素光激活人工胰腺系统中。